Isthmus Partners’s Bio-Techne TECH Stock Holding History

Isthmus Partners’s Portfolio TECH Stock Details TECH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-3,845	Closed	-$297K	–	206
2023 Q4	$297K	Buy	+3,845	New	+$253K	0.04%	162

Other funds holding TECH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return

DDC

DF Dent & Co Baltimore, Maryland $5.27B AUM 7.89% 1-Year Est. Return

Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return

Isthmus Partners's TECH Position: Q1 2024 in Review

Isthmus Partners sold out of Bio-Techne (TECH) in Q1 2024, closing a stake of 3,845 shares — an estimated $297K sold.

Isthmus Partners first reported a position in TECH in Q4 2023 and held it in 1 quarter. The position peaked at $297K in Q4 2023. 557 funds tracked by Wall St. Rank hold TECH as of Q1 2024.

Isthmus Partners reported no remaining Bio-Techne position as of Q1 2024 after selling out during the quarter.
Isthmus Partners sold 3,845 Bio-Techne shares in Q1 2024, an estimated $297K.
Isthmus Partners first reported a position in Bio-Techne in Q4 2023 and held it in 1 quarter.
Isthmus Partners's Bio-Techne position peaked at $297K in Q4 2023.
557 funds tracked by Wall St. Rank held Bio-Techne as of Q1 2024.

Based on Isthmus Partners's 13F filing for Q1 2024, filed 8 May 2024.